After completing a Bachelor of Pharmaceutical Sciences, Negin started her career at Nucleus Network where she gained an in-depth and hands-on understanding of early phase clinical trials.
Negin advanced her career working across a broad range of therapeutic areas from monitoring and management of clinical trials to leading national product launches for pharmaceutical companies and CROs.
In devoting her career towards understanding innovation and change within the industry, Negin decided to apply her experience and expertise in helping research services understand the gaps and opportunities in the industry.
She built CPC as an Australian CRO, specialising in early phase trials that can provide a much-needed, holistic approach to short-term and long-term solutions.
Patrick is a passionate and self-motivated drug discovery and development professional.
With five years as a postdoctoral researcher in the United States, and five and a half years as a senior pharmacology scientist in China, Patrick has a deep working knowledge of, and experience in, the fields of pharmacology research, drug discovery, in-vivo pharmacodynamics, preclinical development, and IND regulatory file preparation.
His expertise and long experience in the above fields have contributed to 21 publications and multiple first-in class INDs .
Working closely with Negin, Patrick is driving research and business outcomes for Chinese products to move through the Australian clinical trial framework, allowing for a global reach for clients.
Amy is a highly-motivated professional holding years of experience in the pharmaceutical industry across quality management, audit preparation, and protocol training and education for clients.
With a strong passion for driving research-based outcomes in the pharmaceutical industry, Amy finds great joy in providing tailored services to meet her clients'needs.